Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-21

Clinical Trial Update: Characteristics of Pts Initiating Spiriva Respimat in Asthma

View source ↗

Summary

This clinical trial update describes the characteristics of asthma patients initiating Spiriva Respimat (tiotropium) in a completed study, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SPIRIVA RESPIMAT (tiotropium bromide inhalation spray)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Asthma | Status: COMPLETED | Results posted: 2020-12-21